Previous Members

Graduate Student (2022 - 2024)

Stephen joined the Gallego-Perez Nanomedicine Lab in 2019 during his undergraduate tenure, then following graduation, transitioned into his Masters in August of 2022. His research focused on the use of myeloid-lineage immune cells as mediators of therapeutic drug delivery. His initial work demonstrated this technique to deliver tumor suppressor genes to mesenchymal breast cancer cells, which were then able to mitigate tumor growth and invasion. In May of 2022, Daniel was awarded the Presidential Fellowship from Ohio State, one of the school’s premier graduate fellowships, to pursue similar research in cerebrovascular disorders. He focused on the use of electroporation-based techniques, combined with a pro-angiogenic cocktail of transcription factor plasmid DNA, to potentiate re-vascularization of ischemic brain tissue. Daniel presented his work at several local and international conferences, including as a featured podium speaker at the 2022 annual Society for Neuroscience meeting in San Diego, CA. Following graduation, Daniel accepted a position as a research scientist at InfinixBio, a contract research organization in Columbus, OH.

Graduate Student (2021- 2024)

Ana joined the Gallego-Perez Nanomedicine Lab in 2019 during his undergraduate tenure, then following graduation, transitioned into his PhD in August of 2019. His research focused on the use of myeloid-lineage immune cells as mediators of therapeutic drug delivery. His initial work demonstrated this technique to deliver tumor suppressor genes to mesenchymal breast cancer cells, which were then able to mitigate tumor growth and invasion. In May of 2022, Daniel was awarded the Presidential Fellowship from Ohio State, one of the school’s premier graduate fellowships, to pursue similar research in cerebrovascular disorders. He focused on the use of electroporation-based techniques, combined with a pro-angiogenic cocktail of transcription factor plasmid DNA, to potentiate re-vascularization of ischemic brain tissue. Daniel presented his work at several local and international conferences, including as a featured podium speaker at the 2022 annual Society for Neuroscience meeting in San Diego, CA. Following graduation, Daniel accepted a position as a research scientist at InfinixBio, a contract research organization in Columbus, OH.

Graduate Student (2019 - 2024)

William joined the Gallego-Perez Nanomedicine Lab in 2019 during his undergraduate tenure, then following graduation, transitioned into his PhD in August of 2019. His research focused on the use of myeloid-lineage immune cells as mediators of therapeutic drug delivery. His initial work demonstrated this technique to deliver tumor suppressor genes to mesenchymal breast cancer cells, which were then able to mitigate tumor growth and invasion. In May of 2022, Daniel was awarded the Presidential Fellowship from Ohio State, one of the school’s premier graduate fellowships, to pursue similar research in cerebrovascular disorders. He focused on the use of electroporation-based techniques, combined with a pro-angiogenic cocktail of transcription factor plasmid DNA, to potentiate re-vascularization of ischemic brain tissue. Daniel presented his work at several local and international conferences, including as a featured podium speaker at the 2022 annual Society for Neuroscience meeting in San Diego, CA. Following graduation, Daniel accepted a position as a research scientist at InfinixBio, a contract research organization in Columbus, OH.

Graduate Student (2019 - 2023)

Daniel joined the Gallego-Perez Nanomedicine Lab in 2018 during his undergraduate tenure, then following graduation, transitioned into his PhD in August of 2019. His research focused on the use of myeloid-lineage immune cells as mediators of therapeutic drug delivery. His initial work demonstrated this technique to deliver tumor suppressor genes to mesenchymal breast cancer cells, which were then able to mitigate tumor growth and invasion. In May of 2022, Daniel was awarded the Presidential Fellowship from Ohio State, one of the school’s premier graduate fellowships, to pursue similar research in cerebrovascular disorders. He focused on the use of electroporation-based techniques, combined with a pro-angiogenic cocktail of transcription factor plasmid DNA, to potentiate re-vascularization of ischemic brain tissue. Daniel presented his work at several local and international conferences, including as a featured podium speaker at the 2022 annual Society for Neuroscience meeting in San Diego, CA. Following graduation, Daniel accepted a position as a research scientist at InfinixBio, a contract research organization in Columbus, OH.

Graduate Student (2018 - 2022)

Jordan joined the Gallego-Perez Nanomedicine Lab as a research assistant in 2016, then transitioned into his PhD in 2018. His research focused on using nano-transfection based methods to assist in the repair of peripheral nerves following traumatic injury. Jordan was awarded a F99/K00 Predoctoral to Postdoctoral Fellow Transition Award from the NIH in 2021. He was named as a Purdue Black Trailblazer in Engineering in 2020 and has presented his work at several events throughout his career, including the Society for Neuroscience and the Biomedical Engineering Society. Jordan successfully defended his thesis in the December 2022, which is titled "Nanomedicine-Based Strategies for Peripheral Nerve Injury". Following graduation, Jordan began working as a post-doctoral fellow at Stanford University.

Visiting Scholar and Postdoctoral Researcher (2021 - 2022)

Hatice was a visiting scholar in the Gallego-Perez Nanomedicine Lab located in the Biomedical and Materials Engineering Complex. She was also the winner of the TUBITAK 2219 Scholarship from Türkiye. Additionally, she is an Assistant Professor and Assistant Principal at Istanbul Atlas University, Vocational School, Department of Medical Laboratory Tecniqiues. Her research focuses on microbiological applications in biotechnology and medical science. Her research specializes in bacterial resistance and antimicrobials on pathogen microorganisms. During her tenure in the Gallego-Perez Lab, she worked on tissue nanotransfection to combat biofilm infections in wounds.

Graduate Student (2019 - 2022)

Luke joined the Gallego-Perez Nanomedicine Lab as a research assistant in 2018, then transitioned into his PhD in 2019. His research focused on using nano-transfection based methods to reprogram fibroblasts into different cell lineages for therapeutic outcomes in stroke and diabetes. Luke was awarded a distinguished university fellowship during his time as a doctoral candidate and was a finalist for the university's Three Minute Thesis competition in 2021. Luke earned several publications throughout his time in the Nanomedicine Lab, and presented at the Biomedical Engineering Society national conference on stroke therapies. Luke successfully defended his thesis in the summer of 2022, which is titled "Development of Cell-based Therapies for Ischemic Stroke and Type I Diabetes using Nanotechnology-based Cell Reprogramming". Following his tenure, Luke began working with Sarepta Therapeutics.

Graduate Student (2017 - 2020); Post-Doctoral Researcher (2020 - 2021)

Silvia was a PhD student in the Interdisciplinary Program in Nutrition and post-doctoral researcher in the Gallego-Perez Nanomedicine Lab. Her research focused on developing novel nanoscale tools for inflammation and immunomodulation within the context of cancer and diabetes (Thesis title: “Nanotechnology-based approaches towards modulating inflammation”). She was awarded the AHA predoctoral fellowship in 2018, and was one of the finalist for the Millipore Sigma Life Science Award for Tumor Biology. As a finalist, Silvia was invited to go to Germany to present her work on “Nanotechnology-based approaches towards elucidating and modulating the immunology of the tumor niche”. Silvia defended her thesis in the spring of 2021 and began working with Andelyn Biosciences.